These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36237627)

  • 21. Short-term neuropsychiatric outcomes and quality of life in COVID-19 survivors.
    Méndez R; Balanzá-Martínez V; Luperdi SC; Estrada I; Latorre A; González-Jiménez P; Feced L; Bouzas L; Yépez K; Ferrando A; Hervás D; Zaldívar E; Reyes S; Berk M; Menéndez R
    J Intern Med; 2021 Sep; 290(3):621-631. PubMed ID: 33533521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Examining the Long-Term Sequelae of SARS-CoV2 Infection in Patients Seen in an Outpatient Psychiatric Department.
    Farooqi M; Khan A; Jacobs A; D'Souza V; Consiglio F; Karmen CL; Dornbush R; Hasnat GS; Ferrando SJ
    Neuropsychiatr Dis Treat; 2022; 18():1259-1268. PubMed ID: 35761861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-COVID-19 neuropsychiatric manifestations among COVID-19 survivors suffering from migraine: a case-control study.
    Magdy R; Elmazny A; Soliman SH; Elsebaie EH; Ali SH; Abdel Fattah AM; Hassan M; Yassien A; Mahfouz NA; Elsayed RM; Fathy W; Abdel-Hamid HM; Mohamed J; Hussein M
    J Headache Pain; 2022 Aug; 23(1):101. PubMed ID: 35962348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On Patterns of Neuropsychiatric Symptoms in Patients With COVID-19: A Systematic Review of Case Reports.
    Idehen JB; Kazi U; Quainoo-Acquah JA; Sperry B; Zaman I; Goodarzi A; Chida S; Nalbandyan L; Hernandez EW; Sharma V; Mulume R; Okoh OM; Okonkwo I; Harrison H; Soetan OT; Iqbal R; Lesniowska MK; Baloch AH; Jolayemi A
    Cureus; 2022 May; 14(5):e25004. PubMed ID: 35712343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropsychiatric sequelae of long COVID-19: Pilot results from the COVID-19 neurological and molecular prospective cohort study in Georgia, USA.
    Chen AK; Wang X; McCluskey LP; Morgan JC; Switzer JA; Mehta R; Tingen M; Su S; Harris RA; Hess DC; Rutkowski EK
    Brain Behav Immun Health; 2022 Oct; 24():100491. PubMed ID: 35873350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired eye movements in post-concussion syndrome indicate suboptimal brain function beyond the influence of depression, malingering or intellectual ability.
    Heitger MH; Jones RD; Macleod AD; Snell DL; Frampton CM; Anderson TJ
    Brain; 2009 Oct; 132(Pt 10):2850-70. PubMed ID: 19617197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms.
    Troyer EA; Kohn JN; Hong S
    Brain Behav Immun; 2020 Jul; 87():34-39. PubMed ID: 32298803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. One year follow-up of physical performance and quality of life in patients surviving COVID-19: a prospective cohort study.
    Betschart M; Rezek S; Unger I; Ott N; Beyer S; Böni A; Gisi D; Shannon H; Spruit MA; Sieber C
    Swiss Med Wkly; 2021 Oct; 151():w30072. PubMed ID: 34751538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma Biomarkers of Neuropathogenesis in Hospitalized Patients With COVID-19 and Those With Postacute Sequelae of SARS-CoV-2 Infection.
    Hanson BA; Visvabharathy L; Ali ST; Kang AK; Patel TR; Clark JR; Lim PH; Orban ZS; Hwang SS; Mattoon D; Batra A; Liotta EM; Koralnik IJ
    Neurol Neuroimmunol Neuroinflamm; 2022 May; 9(3):. PubMed ID: 35256481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 pandemic and mental health consequences: Systematic review of the current evidence.
    Vindegaard N; Benros ME
    Brain Behav Immun; 2020 Oct; 89():531-542. PubMed ID: 32485289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fatigue in patients with systemic lupus erythematosus and neuropsychiatric symptoms is associated with anxiety and depression rather than inflammatory disease activity.
    Monahan RC; Beaart-van de Voorde LJ; Eikenboom J; Fronczek R; Kloppenburg M; Middelkoop HA; Terwindt GM; van der Wee NJ; Huizinga TW; Steup-Beekman GM
    Lupus; 2021 Jun; 30(7):1124-1132. PubMed ID: 33779389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construct validity of the Post-COVID-19 Functional Status Scale in adult subjects with COVID-19.
    Machado FVC; Meys R; Delbressine JM; Vaes AW; Goërtz YMJ; van Herck M; Houben-Wilke S; Boon GJAM; Barco S; Burtin C; van 't Hul A; Posthuma R; Franssen FME; Spies Y; Vijlbrief H; Pitta F; Rezek SA; Janssen DJA; Siegerink B; Klok FA; Spruit MA
    Health Qual Life Outcomes; 2021 Feb; 19(1):40. PubMed ID: 33536042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depressive and Neurocognitive Disorders in the Context of the Inflammatory Background of COVID-19.
    Dąbrowska E; Galińska-Skok B; Waszkiewicz N
    Life (Basel); 2021 Oct; 11(10):. PubMed ID: 34685427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Previous History of Migraine Is Associated With Fatigue, but Not Headache, as Long-Term Post-COVID Symptom After Severe Acute Respiratory SARS-CoV-2 Infection: A Case-Control Study.
    Fernández-de-Las-Peñas C; Gómez-Mayordomo V; García-Azorín D; Palacios-Ceña D; Florencio LL; Guerrero AL; Hernández-Barrera V; Cuadrado ML
    Front Hum Neurosci; 2021; 15():678472. PubMed ID: 34295230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Examining Association of Personality Characteristics and Neuropsychiatric Symptoms in Post-COVID Syndrome.
    Delgado-Alonso C; Valles-Salgado M; Delgado-Álvarez A; Gómez-Ruiz N; Yus M; Polidura C; Pérez-Izquierdo C; Marcos A; Gil MJ; Matías-Guiu J; Matias-Guiu JA
    Brain Sci; 2022 Feb; 12(2):. PubMed ID: 35204028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Refining "Long-COVID" by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 Infection.
    Scherlinger M; Felten R; Gallais F; Nazon C; Chatelus E; Pijnenburg L; Mengin A; Gras A; Vidailhet P; Arnould-Michel R; Bibi-Triki S; Carapito R; Trouillet-Assant S; Perret M; Belot A; Bahram S; Arnaud L; Gottenberg JE; Fafi-Kremer S; Sibilia J
    Infect Dis Ther; 2021 Sep; 10(3):1747-1763. PubMed ID: 34245450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
    Hoşgelen EI; Alptekin K
    Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34750798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
    Hoşgelen EI; Alptekin K
    Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34637131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-COVID-19 functional status: Relation to age, smoking, hospitalization, and previous comorbidities.
    Mohamed Hussein AA; Saad M; Zayan HE; Abdelsayed M; Moustafa M; Ezzat AR; Helmy R; Abd-Elaal H; Aly K; Abdelrheem S; Sayed I
    Ann Thorac Med; 2021; 16(3):260-265. PubMed ID: 34484441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.